Viewing Study NCT02202161


Ignite Creation Date: 2025-12-24 @ 11:52 AM
Ignite Modification Date: 2025-12-28 @ 5:29 PM
Study NCT ID: NCT02202161
Status: COMPLETED
Last Update Posted: 2017-11-06
First Post: 2014-07-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered With Metformin to Type 2 Diabetes Patients
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-08-27
Start Date Type: ACTUAL
Primary Completion Date: 2015-01-30
Primary Completion Date Type: ACTUAL
Completion Date: 2015-01-30
Completion Date Type: ACTUAL
First Submit Date: 2014-07-24
First Submit QC Date: None
Study First Post Date: 2014-07-28
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2017-08-28
Results First Submit QC Date: None
Results First Post Date: 2017-11-06
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2015-06-04
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2017-10-03
Last Update Post Date: 2017-11-06
Last Update Post Date Type: ACTUAL